Chapman Financial Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Chapman Financial Group's LLY Position: Q3 2026 in Review
Chapman Financial Group increased its Eli Lilly (LLY) stake by 75% in Q3 2026, buying an estimated $616K and bringing the position to 1,222 shares worth $1.41M. The position accounts for 0.93% of the portfolio, ranked #23.
Chapman Financial Group first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 1,741 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Chapman Financial Group held 1,222 shares of Eli Lilly worth $1.41M as of Q3 2026.
- Chapman Financial Group bought 522 Eli Lilly shares in Q3 2026, an estimated $616K.
- Eli Lilly made up 0.93% of Chapman Financial Group's portfolio in Q3 2026, its #23 holding.
- Chapman Financial Group first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
- 1,741 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Chapman Financial Group's 13F filing for Q3 2026, filed 26 Oct 2026.